Use of Clozapine for the Treatment of Schizophrenia: Findings of the 2006 Research on the China Psychotropic Prescription Studies

Abstract

ObjectiveClozapine is one of the most commonly used antipsychotic drugs in China. To date, few studies have investigated the patterns the prescription of clozapine nationwide. The present study examined these patterns in China in 2006 and identified the demographic and clinical characteristics associated with the use of clozapine.MethodsUsing a standardized protocol and data collection procedure, we surveyed 5,898 patients with schizophrenia in 10 provinces with differing levels of economic development.ResultsOverall, clozapine had been prescribed for 31.9% (n=1,883) of the patients; however we found considerable variation among the 10 provinces. The frequency of clozapine use was highest in Sichuan (39.3%) and lowest in Beijing (17.3%). The mean daily dose of clozapine was 210.36±128.72 mg/day, and 25.1% of the patients were treated with clozapine in combination with other antipsychotics. Compared with the group not receiving clozapine, clozapine-user had been treated for longer durations and had experienced a greater number of relapses and hospitalizations. Furthermore, those in the clozapine-user had lower family incomes, were less able to seek psychiatric services, and more likely to be male and have a positive family history of schizophrenia. A multiple logistic regression analysis revealed that age, sex, professional help-seeking behaviors, duration of illness, economic status, educational level, and clinical manifestations were associated with the use of clozapine.ConclusionClozapine use is common in China. However, use of the antipsychotic varies among provinces, and demographic and clinical factors play important roles in the prescription of clozapine.

Clozapine in the Time of COVID-19

“…Clozapine is the most effective antipsychotic for reducing positive symptoms, is widely used [ 7 ] and is the best, if not the only, therapeutic option for patients with treatment resistant schizophrenia [ 8 ]. Interruption of clozapine treatment can precipitate dramatic psychotic relapses in patients who have responded to it [ 8 ], while delays in starting clozapine could mean many wasted years of otherwise treatable psychosis to those who need it [ 9 ].…”

Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine

“…It also shows a potent antagonism of 5-HT 2A and 5-HT 2C serotonergic, α 1 -adrenergic, muscarinic and H 1 histamine receptors 1. Clozapine has been widely used following its introduction, because it induces relatively few extrapyramidal effects, and it shows therapeutic benefits for patients who have failed to respond to other agents 3. Clozapine is absorbed rapidly and undergoes extensive hepatic metabolism 4.…”

Clozapine Monitoring in Clinical Practice: Beyond the Mandatory Requirement

“…The reported proportions, however, vary considerably in different regions, e.g., it is around 10–20% in United States,2) 14.5–15.9% in hospitalised schizophrenia patients in 9 Asian countries;3) whereas higher figures have been reported by studies in China (31.9%),4) Australia (33.3%) and the United Kingdom (54%) 5,6). Its initiation is also usually delayed 7).…”